Open partial nephrectomy: current review.
Renal neoplasm
complications
minimally invasive surgical procedures
nephron
organ preservation
urological surgical procedures
Journal
Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
18
1
2021
pubmed:
19
1
2021
medline:
19
1
2021
Statut:
ppublish
Résumé
Partial nephrectomy (PN) is increasingly considered the gold standard treatment for localized renal cell carcinomas (RCCs) where technically feasible. The advantage of nephron-sparing surgery lies in preservation of parenchyma and hence renal function. However, this advantage is counterbalanced with increased surgical risk. In recent years with the popularization of minimally invasive partial nephrectomy (laparoscopic and robotic), the contemporary role of open PN (OPN) has changed. OPN has several advantages, particularly in complex patients such as those with a solitary kidney, multi-focal tumors, and significant surgical history, as well as providing improved application of renoprotective measures. As such, it is a technique that remains relevant in current urology practice. In this article we discuss the evidence, indications, operative considerations and surgical technique, along with the role of OPN in contemporary nephron-sparing surgery.
Identifiants
pubmed: 33457287
doi: 10.21037/tau-20-474
pii: tau-09-06-3149
pmc: PMC7807322
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
3149-3159Informations de copyright
2020 Translational Andrology and Urology. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-474). The series “Surgery for Urologic Cancers” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Références
Urology. 2002 Dec;60(6):993-7
pubmed: 12475656
Eur Urol. 2015 Dec;68(6):996-1003
pubmed: 26012710
BJU Int. 2013 Feb;111(2):281-8
pubmed: 22672491
J Urol. 2011 May;185(5):1598-603
pubmed: 21419452
Urol Oncol. 2018 Oct;36(10):471.e1-471.e9
pubmed: 30100111
J Urol. 2005 Mar;173(3):705-8
pubmed: 15711247
BJU Int. 2018 May;121 Suppl 3:40-47
pubmed: 29072806
BJU Int. 2005 Mar;95 Suppl 2:35-40
pubmed: 15720333
BJU Int. 2018 Nov;122 Suppl 5:15-21
pubmed: 30370984
Eur Urol. 2015 Mar;67(3):519-30
pubmed: 25449206
Scand J Surg. 2017 Jun;106(2):139-144
pubmed: 27431979
Eur Urol Oncol. 2019 Sep;2(5):572-575
pubmed: 31412012
Eur Urol. 2009 Nov;56(5):786-93
pubmed: 19665284
BJU Int. 2016 Mar;117(3):531-6
pubmed: 26435486
Cancer. 2008 Jul 1;113(1):78-83
pubmed: 18491376
PLoS One. 2019 Jan 10;14(1):e0210413
pubmed: 30629644
Eur Urol. 2011 Apr;59(4):543-52
pubmed: 21186077
Eur Urol Oncol. 2018 May;1(1):61-68
pubmed: 31100229
Cochrane Database Syst Rev. 2013 Sep 11;(9):CD003590
pubmed: 24027097
Eur Urol. 2012 Apr;61(4):757-63
pubmed: 22136987
J Nephrol. 2019 Aug;32(4):539-547
pubmed: 30635875
BJU Int. 2017 Mar;119(3):430-435
pubmed: 27480607
Eur Urol. 2009 Oct;56(4):625-34
pubmed: 19656615
PLoS One. 2014 Feb 21;9(2):e89155
pubmed: 24586557
Medicine (Baltimore). 2018 Aug;97(34):e11856
pubmed: 30142777
Urology. 2014 Feb;83(2):339-44
pubmed: 24246321
Urol Oncol. 2015 Oct;33(10):427.e11-6
pubmed: 26145460
Eur Urol Oncol. 2019 Jul;2(4):343-348
pubmed: 31277771
Int J Surg. 2016 Dec;36(Pt C):541-547
pubmed: 27174506
J Urol. 2009 Sep;182(3):844-53
pubmed: 19616235
World J Urol. 2019 Mar;37(3):515-522
pubmed: 30043248
Urol Oncol. 2004 Jan-Feb;22(1):36-9
pubmed: 14969802
Eur Urol. 2015 Oct;68(4):632-40
pubmed: 25922273
BJU Int. 2009 Aug;104(4):470-5
pubmed: 19239445
J Urol. 2008 Jan;179(1):67-70
pubmed: 17997447
J Urol. 2008 Feb;179(2):468-71; discussion 472-3
pubmed: 18076931
J Endourol. 2017 Sep;31(9):893-909
pubmed: 27305835
Eur Urol Focus. 2021 Mar;7(2):397-403
pubmed: 31685445
J Urol. 2010 May;183(5):1708-13
pubmed: 20299047
Ann Surg Oncol. 2016 Dec;23(13):4277-4283
pubmed: 27411552
Eur Urol. 2019 May;75(5):799-810
pubmed: 30803729
J Urol. 2008 Jul;180(1):89-93; discussion 93
pubmed: 18485404
Int J Med Robot. 2019 Feb;15(1):e1963
pubmed: 30265760
Eur Urol. 2018 Jan;73(1):53-59
pubmed: 28822586
J Urol. 2018 Oct;200(4):731-736
pubmed: 29653161
BJU Int. 2014 Dec;114(6):872-80
pubmed: 24274617
World J Urol. 2020 May;38(5):1113-1122
pubmed: 31701211
AJR Am J Roentgenol. 2005 May;184(5):1661-4
pubmed: 15855135
BMJ Open. 2019 Jan 3;9(1):e025662
pubmed: 30610026
J Urol. 2011 Aug;186(2):411-5
pubmed: 21683403
BJU Int. 2019 Feb;123(2):210-219
pubmed: 29726092
World J Urol. 2018 Apr;36(4):557-563
pubmed: 29372352
Clin Genitourin Cancer. 2019 Feb;17(1):46-57.e5
pubmed: 30391138
J Urol. 2010 May;183(5):1719-24
pubmed: 20299057
Front Oncol. 2019 Jul 18;9:648
pubmed: 31380284
Arch Esp Urol. 2011 Sep;64(7):571-93
pubmed: 21965255
BJU Int. 2006 Jan;97(1):149-56
pubmed: 16336347
Int Urol Nephrol. 2015 Dec;47(12):1923-32
pubmed: 26438327
BJU Int. 2006 Feb;97(2):342-4
pubmed: 16430643
J Robot Surg. 2019 Jun;13(3):401-405
pubmed: 30171484
Can J Urol. 2013 Jun;20(3):6778-84
pubmed: 23783047
Anticancer Res. 2018 Jul;38(7):4123-4130
pubmed: 29970539
Eur Urol. 2012 May;61(5):972-93
pubmed: 22405593
World J Surg Oncol. 2018 Feb 20;16(1):35
pubmed: 29463251
Eur Urol. 2015 Jul;68(1):61-74
pubmed: 25703575
Urol Clin North Am. 2008 Nov;35(4):543-9; v
pubmed: 18992608
J Urol. 2008 Dec;180(6):2363-8; discussion 2368-9
pubmed: 18930264
Urology. 2020 Jan;135:76-81
pubmed: 31536739
Lancet. 2016 Feb 27;387(10021):894-906
pubmed: 26318520
Eur Urol Focus. 2021 Mar;7(2):390-396
pubmed: 31727523